Clinical trial · Observational
Resiliency in Patients Undergoing Radical Cystectomy for Bladder Cancer
NCT06337305CI-TRIAL-00081522completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This is a prospective cross-sectional survey-based study composed of both a retrospective chart review and 3-series patient survey. This study will help elicit potential areas throughout the perioperative course of radical cystectomy to improve patient resilience and quality of life, providing opportunity for future interventional studies.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Bladder Cancer | Malignant Bladder Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (1)
- label
- Bladder cancer patients undergoing radical cystectomy.
- description
- This is a prospective cross-sectional survey of bladder cancer patients undergoing radical cystectomy.
Primary outcomes (3)
- measure
- Change in resiliency as measured by the Connor-Davidson Resilience Scale (CD-RISC-25).
- timeFrame
- Prior to radical cystectomy, 10-30-days post-operative, and 90-days (+/-30-days) post-operative
- description
- The Connor-Davidson Resilience scale is a 25-item self-administered instrument for assessing resilience that is consistent in a variety of populations, including clinical and community. Scoring: 0-100 (sum total of all items, each of which is scored 0-4). Higher score reflects greater resilience.
- measure
- Change in quality of life in patients undergoing radical cystectomy as measured by the Functional Assessment of Cancer Therapy-Bladder-Cystectomy (FACT-Bl-Cys).
- timeFrame
- Prior to radical cystectomy, 10-30-days post-operative, and 90-days (+/-30-days) post-operative
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients with a diagnosis of bladder cancer * Patients electing to undergo radical cystectomy as treatment * ≥ 18 years of age * Able to speak and read English * Willing and able to provide informed consent * Functioning telephone number or access to one Exclusion Criteria: * Patients opting to not undergo radical cystectomy * Minors
References
Publications (0)
Data not yet available
No reference posted for this study.